180 Life Sciences Corp. announced that it has appointed Pamela Marrone, PhD, and Frank Knuettel II, MBA, to its Board of Directors (“Board”) effective upon the earlier of (a) the business day following the filing of the 2020 Form 10-K Annual Report; and (b) June 28, 2021. The Board also changed the effective dates of the appointments of Russell T. Ray, MBA and Teresa DeLuca MD, MBA as members of the Board, as previously announced on May 27, 2021, to the same effective date as the appointments of Dr. Marrone and Mr. Knuettel. From founding in 2006 to August 2020, Dr. Marrone was CEO and board member of Marrone Bio Innovations Inc. and remains a board member and advisor. Knuettel was formerly Director of Capital and Advisory at Viridian Capital Advisors.